Insight

Thejus Jayakrishnan: Tolerance to therapy for patients with early-onset vs average-onset locally advanced rectal cancer

Photo from Thejus Jayakrishnan/X

Jun 17, 2025, 22:24

Thejus Jayakrishnan: Tolerance to therapy for patients with early-onset vs average-onset locally advanced rectal cancer

Thejus Jayakrishnan, Gastrointestinal Oncologist at Dana-Farber Cancer Institute, shared a post on X:

“Tolerance to therapy for patients with early-onset vs average-onset locally advanced rectal cancer by Madison Conces, Smitha Krishnamurthi. Early-onset leads to significantly more nausea, fatigue and side effects Consider enhanced antiemetic prophylaxis.”

Title: Total neoadjuvant therapy in early-onset versus average-onset locally advanced rectal cancer: patient characteristics and tolerance of therapy

Authors: M.L. Conces, N. Tursun, I. Ozgur, S. Yilmaz, D. Elamin, S. Patil, Y. Bouferra, E. Gorgun, D. Liska, E. Weinstein, S.D. Kamath, S.R. Steele, A.A. Khorana, B. Laderian, T.T. Jayakrishnan, K.G. Nair, S.R. Amarnath, E.H. Balagamwala, B.N. Estfan, H. Kessler, M.J. McNamara, M.A. Shapiro, M.A. Valente, S.S. Krishnamurthi

Read the Full Article.

Thejus Jayakrishnan

A.A. Khorana B. Laderian B.N. Estfan cancer D. Elamin D. Liska E. Gorgun E. Weinstein E.H. Balagamwala H. Kessler I. Ozgur K.G. Nair M.A. Shapiro M.A. Valente M.J. McNamara M.L. Conces Madison Conces N. Tursun OncoDaily Oncology S. Patil S. Yilmaz S.D. Kamath S.R. Amarnath S.R. Steele S.S. Krishnamurthi Smitha Krishnamurthi T.T. Jayakrishnan Thejus Jayakrishnan Y. Bouferra

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine

Smoking and Bladder Cancer: What You Need to Know to Protect Yourself

Cervical Cancer Screening: Who Needs a Pap Smear or HPV Test and When?

Clinical Trials in Cancer Care: What They Are, How to Join, and What to Expect

Linda Evangelista and Breast Cancer: How She Went Against, How She Survived, and More